Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients.

@article{Oldani2012PlasmaPA,
  title={Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients.},
  author={Silvia Oldani and Silvia Finazzi and Barbara Bottazzi and Cecilia Garlanda and Eleonora Baldassarre and Serenella Valaperta and Ivan Cuccovillo and Marco Albini and Maurice Child and Alessandro Montanelli and Giorgio Graziani and Salvatore Badalamenti},
  journal={Journal of nephrology},
  year={2012},
  volume={25 1},
  pages={120-6}
}
INTRODUCTION Hemodialysis (HD)-induced inflammation has a pathogenetic role in patients with end-stage renal disease (ESRD). The aim of the present study was to assess whether pentraxin-3 (PTX3) could be a reliable biomarker of HD-induced inflammation and of membrane biocompatibility. METHODS We prospectively enrolled 31 HD patients. Blood samples for determining PTX3, C-reactive protein (CRP), leukocytes and neutrophils were drawn from the arterial needle, before dialysis after the long… CONTINUE READING